Published in Invest Ophthalmol Vis Sci on September 01, 1997
Novel aspects of corneal angiogenic and lymphangiogenic privilege. Prog Retin Eye Res (2010) 1.33
Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration. Cochrane Database Syst Rev (2013) 0.89
Localization of angiotensin converting enzyme in rabbit cornea and its role in controlling corneal angiogenesis in vivo. Mol Vis (2010) 0.88
Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration. Cochrane Database Syst Rev (2007) 0.84
Hemangiogenesis and lymphangiogenesis in corneal pathology. Cornea (2012) 0.84
Clinical correlates of common corneal neovascular diseases: a literature review. Int J Ophthalmol (2015) 0.82
Safety of posterior juxtascleral depot administration of the angiostatic cortisene anecortave acetate for treatment of subfoveal choroidal neovascularization in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2004) 0.82
NPR-B natriuretic peptide receptors in human corneal epithelium: mRNA, immunohistochemistochemical, protein, and biochemical pharmacology studies. Mol Vis (2010) 0.78
Efficacy of systemic vitamin C supplementation in reducing corneal opacity resulting from infectious keratitis. Medicine (Baltimore) (2014) 0.75
Fasudil hydrochloride, a potent ROCK inhibitor, inhibits corneal neovascularization after alkali burns in mice. Mol Vis (2015) 0.75
Anecortave acetate in the treatment of age-related macular degeneration. Clin Interv Aging (2006) 0.75
Identification of a gene that causes primary open angle glaucoma. Science (1997) 8.14
Retracted Characterization of a transformed rat retinal ganglion cell line. Brain Res Mol Brain Res (2001) 2.59
Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor. Hum Mol Genet (2001) 1.67
Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma. Prog Retin Eye Res (1999) 1.55
A particle bound intermediate in the biosynthesis of plant cell wall polysaccharides. Biochem Biophys Res Commun (1969) 1.30
Cultured human trabecular meshwork cells express functional growth factor receptors. Invest Ophthalmol Vis Sci (1998) 1.28
Uveitis in children and adolescents. Br J Ophthalmol (2005) 1.24
In vivo angiogenic activity of interleukins. Arch Ophthalmol (1990) 1.23
Preliminary characterization of a transformed cell strain derived from human trabecular meshwork. Curr Eye Res (1994) 1.22
AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor. J Pharmacol Exp Ther (1999) 1.19
Immortalized human corneal epithelial cells for ocular toxicity and inflammation studies. Invest Ophthalmol Vis Sci (1999) 1.18
The problem of catheter encrustation. Can Med Assoc J (1974) 1.17
Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension. Invest Ophthalmol Vis Sci (2001) 1.16
Dexamethasone induced ultrastructural changes in cultured human trabecular meshwork cells. Curr Eye Res (1993) 1.13
The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci (2001) 1.13
The effects of dexamethasone on fibronectin expression in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci (1992) 1.13
The pharmacological properties of the peptide, endothelin. Br J Pharmacol (1989) 1.12
Optimal procedure for extracting RNA from human ocular tissues and expression profiling of the congenital glaucoma gene FOXC1 using quantitative RT-PCR. Mol Vis (2001) 1.10
Camphor binding by Pseudomonas putida cytochrome P-450. Kinetics and thermodynamics of the reaction. Biochemistry (1972) 1.06
Neurotrophin and neurotrophin receptor expression by cells of the human lamina cribrosa. Invest Ophthalmol Vis Sci (2001) 1.05
Localization of MYOC transcripts in human eye and optic nerve by in situ hybridization. Invest Ophthalmol Vis Sci (2000) 1.05
Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs. Arch Ophthalmol (1999) 1.04
Delayed secondary glucocorticoid responsiveness of MYOC in human trabecular meshwork cells. Invest Ophthalmol Vis Sci (2001) 1.03
High-affinity arabinose transport mutants of Escherichia coli: isolation and gene location. J Bacteriol (1981) 1.02
Early graft function and patient survival following cadaveric renal transplantation. Kidney Int (1999) 1.02
Oxidative stress, mitochondrial dysfunction and calcium overload in human lamina cribrosa cells from glaucoma donors. Mol Vis (2011) 1.00
Pharmacological characterization of an FP prostaglandin receptor on rat vascular smooth muscle cells (A7r5) coupled to phosphoinositide turnover and intracellular calcium mobilization. J Pharmacol Exp Ther (1998) 0.98
The effect of dexamethasone on integrin and laminin expression in cultured human trabecular meshwork cells. Exp Eye Res (1998) 0.98
Anterior chamber-associated immune deviation induced by soluble antigens. Invest Ophthalmol Vis Sci (1989) 0.97
Angiostatic activity of steroids in the chick embryo CAM and rabbit cornea models of neovascularization. J Ocul Pharmacol Ther (1999) 0.97
PD117302: a selective agonist for the kappa-opioid receptor. Br J Pharmacol (1988) 0.96
Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor. Br J Pharmacol (2000) 0.96
Targeted inactivation of the Ren-2 gene in mice. Hypertension (1996) 0.96
Functional testosterone: biochemical assessment of hypogonadism in men--report from a multidisciplinary workshop hosted by the Ontario Society of Clinical Chemists. Aging Male (2007) 0.95
Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat. Br J Pharmacol (1995) 0.95
Ocular penetration of cyclosporin A. III: The human eye. Br J Ophthalmol (1990) 0.95
Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data. J Pharmacol Exp Ther (1998) 0.94
Steroid-induced cataract: new perspective from in vitro and lens culture studies. Exp Eye Res (1997) 0.93
Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist. J Ocul Pharmacol Ther (2001) 0.93
Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: pharmacological characterization using agonists and antagonists. Br J Pharmacol (1999) 0.93
Cross-linked actin networks (CLANs) in bovine trabecular meshwork cells. Exp Eye Res (2009) 0.93
Human corneal epithelial cell functional responses to inflammatory agents and their antagonists. Invest Ophthalmol Vis Sci (1998) 0.93
Rho-Rho kinase pathway in the actomyosin contraction and cell-matrix adhesion in immortalized human trabecular meshwork cells. Mol Vis (2011) 0.92
Spectra of chloroperoxidase compounds II and III. Biochem Biophys Res Commun (1985) 0.91
Ocular penetration of cyclosporin A. The rabbit eye. Invest Ophthalmol Vis Sci (1990) 0.90
Human trabecular meshwork cells secrete neurotrophins and express neurotrophin receptors (Trk). Invest Ophthalmol Vis Sci (2000) 0.90
Fas-activated apoptosis and apoptosis mediators in human trabecular meshwork cells. Exp Eye Res (1999) 0.90
Ubiquitous nonimmunoglobulin p-azobenzenearsonate-binding molecules from lymphoid cells. J Exp Med (1982) 0.90
Altered expression of 3 alpha-hydroxysteroid dehydrogenases in human glaucomatous optic nerve head astrocytes. Neurobiol Dis (2003) 0.89
Quantitative autoradiographic visualization and pharmacology of FP-prostaglandin receptors in human eyes using the novel phosphor-imaging technology. J Ocul Pharmacol Ther (1999) 0.89
Patterns of intraocular inflammation in children. Bull Soc Belge Ophtalmol (2001) 0.88
Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells. Ann Allergy Asthma Immunol (1997) 0.87
Increase in dissociation rate constants of cardiotonic steroid-brain (Na+ + K+)-ATPase complexes by reduction of the unsaturated lactone. J Biol Chem (1975) 0.87
Human ocular perfusion organ culture: a versatile ex vivo model for glaucoma research. J Glaucoma (2000) 0.87
An artificial mannosyl acceptor for GDP-D-mannose: lipid phosphate transmannosylase from Phaseolus aureus. FEBS Lett (1973) 0.87
Dopamine D2-receptors mediate hypothermia in mice: ICV and IP effects of agonists and antagonists. Neurochem Res (1991) 0.87
Effects of two new aldose reductase inhibitors, AL-1567 and AL-1576, in diabetic rats. Metabolism (1987) 0.87
Endogenous EP4 prostaglandin receptors coupled positively to adenylyl cyclase in Chinese hamster ovary cells: pharmacological characterization. Prostaglandins Leukot Essent Fatty Acids (2000) 0.87
Kinetics of 3 H-testosterone metabolism in patients with carcinoma of the prostate: effects of oestrogen administration. Acta Endocrinol (Copenh) (1971) 0.86
FP prostaglandin receptors mediating inositol phosphates generation and calcium mobilization in Swiss 3T3 cells: a pharmacological study. J Pharmacol Exp Ther (1997) 0.86
Effects of l-glutamate and related amino acids upon the release of [3H]dopamine from rat striatal slices. Brain Res (1978) 0.86
Acid phosphatases: androgen dependent markers of rat prostate. Can J Biochem (1976) 0.86
Bilateral anophthalmia and unilateral microphthalmia in two siblings. Ophthalmologica (1989) 0.86
Phospholipid turnover during cell-cycle traverse in synchronous Chinese-hamster ovary cells. Mitogenesis without phosphoinositide breakdown. Biochem J (1988) 0.86
Dehydroepiandrosterone: kinetics of metabolism in normal men and women. J Clin Endocrinol Metab (1978) 0.86
Pseudomonas putida cytochrome P-450: characterization of an oxygenated form of the hemoprotein. Arch Biochem Biophys (1972) 0.86
A randomised controlled multicentre trial of treatments for adolescent anorexia nervosa including assessment of cost-effectiveness and patient acceptability - the TOuCAN trial. Health Technol Assess (2010) 0.85
Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide. Invest Ophthalmol Vis Sci (1993) 0.85
Characterization and autoradiographic localization of TRH receptors in sections of rat brain. Brain Res (1984) 0.84
Electrophysiological properties of cultured human trabecular meshwork cells. Exp Eye Res (1994) 0.84
Serum levels of interleukin-2 receptor in ocular Behçet's disease. Am J Ophthalmol (1993) 0.84
Benzodiazepines compete for thyrotropin-releasing hormone receptor binding: micromolar potency in rat pituitary, retina and amygdala. Neurosci Lett (1983) 0.84
Ocular hypotensive and aqueous outflow-enhancing effects of AL-3037A (sodium ferri ethylenediaminetetraacetate). Exp Eye Res (2001) 0.83
Involvement of radical species in the oxidation of aminopyrine and 4-aminoantipyrine by cumene hydroperoxide in rat liver microsomes. Mol Pharmacol (1981) 0.83
Partial trisomy 15 in a male with severe psychomotor retardation (48, XY, + 15q -, + mar(15)). Am J Med Genet (1982) 0.83
Glycosaminoglycans in the three lobes of the rat prostate following castration and testosterone treatment. Biochem Cell Biol (1996) 0.82
Androgen-independent epithelial cells of the rat ventral prostate. Prostate (1988) 0.82
Evidence for a free radical mechanism of N-demethylation of N,N-dimethylaniline and an analog by hemeprotein--H2O2 systems. Arch Biochem Biophys (1978) 0.82
Inter-laboratory quality control of estrogen and progesterone receptor assays in breast cancer tissue using lyophilised cytosols. Clin Biochem (1985) 0.82
Mechanism of N-demethylation of aminopyrine by hydrogen peroxide catalyzed by horseradish peroxidase, metmyoglobin, and protohemin. Biochemistry (1978) 0.82
Problems associated with the binding of L-glutamic acid to synaptic membranes: methodological aspects. J Neurochem (1980) 0.82
Age-related permeability changes in rabbit corneas. J Ocul Pharmacol Ther (1999) 0.82
An objective look at acid phosphatase determinations: a comparison of biochemical and immunological methods. Br J Urol (1979) 0.82
Dehydroepiandrosterone sulfate: kinetics of metabolism in normal young men and women. Clin Invest Med (1984) 0.81
Absence of pyruvate decarboxylase activity in man: a cause of congenital lactic acidosis. Science (1975) 0.81
The similarity of protein expression in trabecular meshwork and lamina cribrosa: implications for glaucoma. Exp Eye Res (2000) 0.81
Androgen 5 alpha-reductase and 3 alpha-hydroxysteroid dehydrogenase activities in ventral prostate epithelial and stromal cells from immature and mature rats. J Endocrinol (1983) 0.81
Radical mechanism of aminopyrine oxidation by cumene hydroperoxide catalyzed by purified liver microsomal cytochrome P-450. Arch Biochem Biophys (1980) 0.81
Effect of the administration of estrogen on the disappearance of 3H-testosterone in the plasma of human subjects. J Clin Endocrinol Metab (1969) 0.81
Rat brain TRH receptors: kinetics, pharmacology, distribution and ionic effects. Regul Pept (1983) 0.81
Effects of bradykinin on signal transduction, cell proliferation, and cytokine, prostaglandin E2 and collagenase-1 release from human corneal epithelial cells. Br J Pharmacol (1998) 0.81
Codepletion of serotonin and TRH induces apparent supersensitivity of spinal TRH receptors. Eur J Pharmacol (1983) 0.81
Mechanism of halide-stimulated activity of chloroperoxidase evidence for enzymatic formation of free hypohalous acid. Biochem Biophys Res Commun (1983) 0.80